These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 32797222)
1. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Clin Infect Dis; 2020 Aug; 71(4):905-913. PubMed ID: 32797222 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Clin Infect Dis; 2020 Aug; 71(4):e1-e36. PubMed ID: 32628747 [TBL] [Abstract][Full Text] [Related]
3. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32636299 [TBL] [Abstract][Full Text] [Related]
4. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline]. Wagner D; Lange C Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550 [TBL] [Abstract][Full Text] [Related]
5. [Pulmonary Disease caused by less common Nontuberculous Mycobacteria - New international guidelines]. Lange C; Wagner D Dtsch Med Wochenschr; 2022 Sep; 147(17):1114-1121. PubMed ID: 36030784 [TBL] [Abstract][Full Text] [Related]
6. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline]. Wagner D; Lange C Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438 [TBL] [Abstract][Full Text] [Related]
7. Nontuberculous Mycobacteria. Tan S; Kasperbauer S Semin Respir Crit Care Med; 2021 Aug; 42(4):567-586. PubMed ID: 34261181 [TBL] [Abstract][Full Text] [Related]
8. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease. Chae DR; Kim YI; Kee SJ; Kim YH; Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim SO; Kim YC; Lim SC Respiration; 2011; 82(2):124-9. PubMed ID: 20926850 [TBL] [Abstract][Full Text] [Related]
9. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Shakoor S; Shafiq S; Shahid A; Mir F; Ali R; Hasan R Int J Mycobacteriol; 2023; 12(3):310-315. PubMed ID: 37721238 [TBL] [Abstract][Full Text] [Related]
10. Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease. Abate G; Stapleton JT; Rouphael N; Creech B; Stout JE; El Sahly HM; Jackson L; Leyva FJ; Tomashek KM; Tibbals M; Watson N; Miller A; Charbek E; Siegner J; Sokol-Anderson M; Nayak R; Dahlberg G; Winokur P; Alaaeddine G; Beydoun N; Sokolow K; Kown NP; Phillips S; Baker AW; Turner N; Walter E; Guy E; Frey S Clin Infect Dis; 2021 Apr; 72(7):1127-1137. PubMed ID: 32198521 [TBL] [Abstract][Full Text] [Related]
11. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614 [TBL] [Abstract][Full Text] [Related]
12. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025 [TBL] [Abstract][Full Text] [Related]
16. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults. Khan O; Chaudary N Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai]. Zheng XB; He YF; Wang L; Sun Q; Shen XN; Wu XC; Yang JH; Yao L; Cui HY; Xu B; Yu FY; Sha W Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):380-387. PubMed ID: 36990702 [No Abstract] [Full Text] [Related]
18. Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review. Metersky ML; Fraulino D; Monday L; Chopra T Postgrad Med; 2024 Sep; 136(7):770-781. PubMed ID: 39259505 [TBL] [Abstract][Full Text] [Related]
19. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex. Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265 [No Abstract] [Full Text] [Related]
20. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases. Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]